Egalet Corporation (NASDAQ:EGLT) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

Egalet Corporation (NASDAQ:EGLT) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders

On May14, 2018, Egalet Corporation (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”). A quorum was present at the Annual Meeting. At the Annual Meeting, the Company’s stockholders voted upon the following proposals: (1)the election of Mr.Robert Radie and Ms.Andrea Heslin Smiley as ClassB directors to the Company’s board of directors; (2)an amendment to the Company’s 2013 Stock-Based Incentive Compensation Plan, as amended, to increase the number of shares of the Company’s common stock available for issuance thereunder by 6,000,000 shares; and (3)the ratification of the appointment of Ernst& Young LLP as the Company’s independent registered public accounting firm for the year ending December31, 2018. The proposals below are described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April6, 2018.

At the Annual Meeting, the Company’s stockholders approved each of the three proposals set forth below, with the final results as follows:

1. The election of Robert Radie and Andrea Heslin Smiley as ClassB directors to hold office until the 2021 Annual Meeting of Stockholders:

Nominees

For

Withheld

BrokerNon-Votes

Robert Radie

19,432,550

1,819,319

21,010,190

Andrea Heslin Smiley

20,085,513

1,166,356

21,010,190

2. The approval of an Amendment to the Company’s 2013 Stock-Based Incentive Compensation Plan, as amended, to increase the number of shares of the Company’s common stock available for issuance thereunder by 6,000,000 shares.

FOR: 18,038,961

AGAINST: 3,176,586

ABSTAIN: 36,322

BROKER NON-VOTES: 21,010,190

3. The ratification of the selection of Ernst& Young LLP as the Company’s independent registered public accounting firm for the year ending December31, 2018:

FOR: 41,026,490

AGAINST: 744,382

ABSTAIN: 491,187

BROKER NON-VOTES: N/A


About Egalet Corporation (NASDAQ:EGLT)

Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company’s products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company’s product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company’s product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company’s product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company’s product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.